HMOX1 and breast carcinoma: HO-1 boosted autophagy modulation by the Src-STAT3 and PI3K/Akt signaling pathways and was also discovered to contribute to doxorubicin and pharmorubicin resistance, respectively, in breast cancer cells [42,43].